PURPOSE: To determine the risk factors associated with progression to blindness from primary open-angle glaucoma (POAG) in an African-American population. METHODS: This study examined 2119 patients enrolled in the Primary Open-Angle African-American Glaucoma Genetics (POAAGG) study. A total of 59 eyes were identified as legally blind as a result of POAG (cases) and were age-and sex-matched to 59 non-blind eyes with glaucoma (controls). Chart reviews were performed to record known and suspected risk factors. RESULTS: Cases were diagnosed with POAG at an earlier age than controls (p = 0.005). Of the 59 eyes of cases, 16 eyes (27.1%) presented with blindness at diagnosis. Cases had worse visual acuity (VA) at diagnosis (p < 0.0001), with VA worse than 20/40 conferring a 27 times higher risk of progression to blindness (p = 0.0005). Blind eyes also demonstrated more visual field defects (p = 0.01), higher pre-treatment intraocular pressure (IOP; p < 0.0001), and higher cup-to-disc ratio (p = 0.006) at diagnosis. IOP was less controlled in cases, and those with IOP ≥21 mmHg at more than 20% of follow-up visits were 73 times more likely to become blind (p < 0.0001). Cases missed a greater number of appointments per year (p = 0.003) and had non-adherence issues noted in their charts more often than controls (p = 0.03). However, other compliance data did not significantly differ between groups. CONCLUSION: Access to care, initial VA worse than 20/40, and poor control of IOP were the major risk factors associated with blindness from POAG. Future studies should examine earlier, more effective approaches to glaucoma screening as well as the role of genetics in these significantly younger patients who progress to blindness.
PURPOSE: To determine the risk factors associated with progression to blindness from primary open-angle glaucoma (POAG) in an African-American population. METHODS: This study examined 2119 patients enrolled in the Primary Open-Angle African-American Glaucoma Genetics (POAAGG) study. A total of 59 eyes were identified as legally blind as a result of POAG (cases) and were age-and sex-matched to 59 non-blind eyes with glaucoma (controls). Chart reviews were performed to record known and suspected risk factors. RESULTS: Cases were diagnosed with POAG at an earlier age than controls (p = 0.005). Of the 59 eyes of cases, 16 eyes (27.1%) presented with blindness at diagnosis. Cases had worse visual acuity (VA) at diagnosis (p < 0.0001), with VA worse than 20/40 conferring a 27 times higher risk of progression to blindness (p = 0.0005). Blind eyes also demonstrated more visual field defects (p = 0.01), higher pre-treatment intraocular pressure (IOP; p < 0.0001), and higher cup-to-disc ratio (p = 0.006) at diagnosis. IOP was less controlled in cases, and those with IOP ≥21 mmHg at more than 20% of follow-up visits were 73 times more likely to become blind (p < 0.0001). Cases missed a greater number of appointments per year (p = 0.003) and had non-adherence issues noted in their charts more often than controls (p = 0.03). However, other compliance data did not significantly differ between groups. CONCLUSION: Access to care, initial VA worse than 20/40, and poor control of IOP were the major risk factors associated with blindness from POAG. Future studies should examine earlier, more effective approaches to glaucoma screening as well as the role of genetics in these significantly younger patients who progress to blindness.
Authors: M Roy Wilson; Omofolasade Kosoko; Claude L Cowan; Pamela A Sample; Chris A Johnson; Gleb Haynatzki; Cheryl Enger; David Crandall Journal: Am J Ophthalmol Date: 2002-09 Impact factor: 5.258
Authors: Sarah E Miller; Suman Thapa; Alan L Robin; Leslie M Niziol; Pradeep Y Ramulu; Maria A Woodward; Indira Paudyal; Ian Pitha; Tyson N Kim; Paula Anne Newman-Casey Journal: Am J Ophthalmol Date: 2017-07-19 Impact factor: 5.258
Authors: Sayoko E Moroi; David M Reed; David S Sanders; Ahmed Almazroa; Lawrence Kagemann; Neil Shah; Nakul Shekhawat; Julia E Richards Journal: Curr Opin Ophthalmol Date: 2019-05 Impact factor: 3.761
Authors: Ebenezer Daniel; Victoria Addis; Maureen G Maguire; Brendan McGeehan; Min Chen; Rebecca J Salowe; Selam Zenebe-Gete; Elana Meer; Roy Lee; Eli Smith; Harini V Gudiseva; Prithvi S Sankar; Joan M O'Brien Journal: Ophthalmol Glaucoma Date: 2022-02-10
Authors: Joan M O'Brien; Rebecca J Salowe; Raymond Fertig; Julia Salinas; Maxwell Pistilli; Prithvi S Sankar; Eydie Miller-Ellis; Amanda Lehman; Windell H A Murphy; Melissa Homsher; Katelyn Gordon; Gui-Shuang Ying Journal: Am J Ophthalmol Date: 2018-03-17 Impact factor: 5.258
Authors: Ava Kikut; Mohima Sanyal; Marquis Vaughn; Katherine Ellen Ridley-Merriweather; Katharine Head; Rebecca Salowe; Sara Lomax-Reese; Monica Lewis; Ahmara G Ross; Qi N Cui; Victoria Addis; Prithvi S Sankar; Eydie Miller-Ellis; Joan M O'Brien Journal: Health Commun Date: 2020-12-19
Authors: Mohammed M Abdull; David C Broadway; Jennifer Evans; Fatima Kyari; Fatima Muazu; Clare Gilbert Journal: Clin Exp Ophthalmol Date: 2018-06-17 Impact factor: 4.207